Rita Raisman-Vozari

Rita Raisman-Vozari publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Rita Raisman-Vozari sits on this spectrum.

Rita Raisman-Vozari D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Rita Raisman-Vozari sits on this spectrum.

Overview

Best Publications

• Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease.

  M.G Murer;Q Yan;R Raisman-Vozari

  1095
  Citations

• Levodopa in the treatment of Parkinson's disease: current controversies.

  C. Warren Olanow;Yves Agid;Yoshi Mizuno;Alberto Albanese

  501
  Citations

• Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease.

  Julio Salazar;Natalia Mena;Stephane Hunot;Annick Prigent

  488
  Citations

• Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra.

  K. Parain;M. G. Murer;Qiao Yan;B. Faucheux

  361
  Citations

• Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions

  M G Murer;G Dziewczapolski;L B Menalled;M C García

  299
  Citations

• Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements.

  M. Vila;C. Périer;J. Féger;J. Yelnik

  270
  Citations

• An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease.

  M.G Murer;F Boissiere;Q Yan;S Hunot

  221
  Citations

• Oxidative Stress Caused by Ozone Exposure Induces Loss of Brain Repair in The Hippocampus of Adult Rats

  Selva Rivas-Arancibia;Rosalinda Guevara-Guzmán;Yolanda López-Vidal;Erika Rodríguez-Martínez

  211
  Citations

• Are dopaminergic neurons selectively vulnerable to Parkinson's disease ?

  Y Agid;M Ruberg;F Javoy-Agid;E Hirsch

  186
  Citations

• Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon

  Veronique Blanchard;Rita Raisman-Vozari;Sheela Vyas;Patrick P. Michel

  175
  Citations

• Novel tactics for neuroprotection in Parkinson's disease: Role of antibiotics, polyphenols and neuropeptides

  Dora Reglodi;Justine Renaud;Andrea Tamas;Yousef Tizabi

  171
  Citations

• Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling Pathways

  Flávia V Santa-Cecília;Benjamin Socias;Mohand O Ouidja;Julia E Sepulveda-Diaz

  171
  Citations

• Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules.

  Henry Jp;Botton D;Sagne C;Isambert Mf

  167
  Citations

• Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease.

  Rui D. S. Prediger;Aderbal S. Aguiar;Argelia Esperanza Rojas-Mayorquin;Argelia Esperanza Rojas-Mayorquin;Argelia Esperanza Rojas-Mayorquin;Claudia P. Figueiredo

  150
  Citations

• Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-κB-dependent signaling and glucose consumption.

  Mauricio dos‐Santos‐Pereira;Mauricio dos‐Santos‐Pereira;Franscisco S. Guimarães;Elaine Del‐Bel;Rita Raisman‐Vozari

  147
  Citations

• Effects of exercise on mitochondrial function, neuroplasticity and anxio-depressive behavior of mice.

  A.S. Aguiar;E. Stragier;D. da Luz Scheffer;A.P. Remor

  137
  Citations

• Levodopa in the treatment of Parkinson's disease: a consensus meeting.

  Y. Agid;E. Ahlskog;A. Albanese;D. Calne

  135
  Citations

• Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson's disease.

  Daniel Rial;Adalberto A. Castro;Nuno Machado;Pedro Garção

  132
  Citations

• The alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cells.

  Pamela Rizk;Julio Salazar;Julio Salazar;Rita Raisman-Vozari;Rita Raisman-Vozari;Marc Marien

  129
  Citations

• Repurposing doxycycline for synucleinopathies: remodelling of α-synuclein oligomers towards non-toxic parallel beta-sheet structured species.

  Florencia González-Lizárraga;Sergio B. Socías;César L. Ávila;Clarisa M. Torres-Bugeau

  125
  Citations

• Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease

  Mariza Bortolanza;Roberta Cavalcanti-Kiwiatkoski;Fernando E. Padovan-Neto;Célia Aparecida da-Silva

  108
  Citations